FDA Preamble FR Notices, Vol 83 No 114 Alternative Mechanisms for CGMP for Combination Products, 06/18 2020-07-30T12:01:09+00:00November 20th, 2019|
FDA Preamble FR Notices, Vol 81 No 223, Medical Gas Containers and Closures; cGMP Requirements, 11/16 2020-07-30T13:10:59+00:00November 20th, 2019|
FDA Preamble FR Notices, Vol 81 No 115, Use of Symbols in Labeling, 06/16 2020-07-30T13:20:24+00:00November 20th, 2019|
FDA Preamble FR Notices, Vol 81 No 244 21 CFR 4 Postmarketing Safety Reporting for Combination Products, 12/16 2021-09-22T15:13:26+00:00November 20th, 2019|
FDA Preamble FR Notices, Vol 61 No 195, 21 CFR 820 Quality System Regulation, 10/96 2020-07-30T12:29:30+00:00November 20th, 2019|
FDA Preamble FR Notices, Human Subject Protection; Acceptance of Data From Clinical Investigations for Medical Devices, 02/18 2021-09-22T14:15:22+00:00November 20th, 2019|
